68 Ga-Radiolabeled AGuIX Nanoparticles as Dual-Modality Imaging Agents for PET/MRI-Guided Radiation Therapy

What is it about?

Ultrasmall AGuIX nanoparticles: David versus Goliath in the fight against cancer Dual-modality imaging agents combine the advantages of two different imaging modalities, for example Positron Emission Tomography (PET) with Magnetic Resonance Imaging (MRI). The present study demonstrates that ultrasmall AGuIX nanoparticles radiolabeled with the positron-emitting radioisotope Gallium-68 is a promising dual-modality imaging agent which effectively accumulates in tumors, thus showing great potential for image-guided radiation therapy of cancer.

Featured Image